The Bridge Project is a collaboration between the Koch Institute and Dana-Farber/Harvard Cancer Center (DF/HCC), designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care. Through seed funding for collaborative research teams comprised of both MIT and DF/HCC investigators, the Bridge Project fosters interdisciplinary studies that wed new tools and methods from the engineering-based disciplines with advances in cancer biology together with the translational expertise of clinical oncologists. Our plan is to raise and deploy a minimum of $15M of innovative investment into transformative target areas over 5 years.
The Bridge Project is designed to reach beyond existing individual networks to establish new ties between unmet clinical needs and technological solutions that have not traditionally been connected. Along with the potential for fundamentally new insights into cancer research, the Bridge Project addresses the substantial challenge in “bridging” a significant divide – in scientific language, experimental approaches, and traditional expertise. Through this program, catalytic financial supports will jumpstart pilot cross-disciplinary, cross-institutional, multi-investigator research.
Click here to learn about the cancer research advances currently being funded by the Bridge Project.
To encourage the formation of cross-institutional research teams, we regularly hold informational sessions, workshops, and symposia based on complex translational problems in cancer. Visit the Bridge Project Events page to learn more and view previous events.
The Bridge Project is led by: